FIELD: medicine. SUBSTANCE: the suggested product is designed as solution for injections and contains clemastine fumarate as active substance and additional substances - sorbitol, 94%-ethanol, sodium citrate dihydrate to achieve certain pH value, and water for injection - at certain quantitative ratio of ingredients. Antihistamine product suggested is nontoxic and causes no local irritating action during its injection. EFFECT: higher efficiency. 2 dwg, 6 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| MEDICINAL AGENT "NOBRASSIT" WITH SEDATIVE AND ANXIOLYTIC EFFECT | 2001 |
|
RU2199309C1 |
| INFUSION SOLUTION "BRAVINTON" FOR IMPROVEMENT OF CEREBRAL CIRCULATION | 2001 |
|
RU2212890C2 |
| AGENT "TSERULAN" ELICITING ANTIEMETIC EFFECT AND REGULATING DIGESTIVE TRACT FUNCTIONS | 2002 |
|
RU2205633C1 |
| STABLE BUDESONIDE-CONTAINING AQUEOUS SOLUTION WITH ANTI-INFLAMMATORY EFFECT | 2000 |
|
RU2180217C2 |
| HEPATOPROTECTING AGENT | 2003 |
|
RU2225715C1 |
| SOLUTION FOR INJECTION "NOSH-BRA" ELICITING SPASMOLYTIC EFFECT | 2001 |
|
RU2199308C1 |
| MUCOLYTIC AGENT "BROMHEXINE-FEREIGN" | 2001 |
|
RU2212234C1 |
| 2-(3-(4-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-1-(ETHYLSULFONYL)AZETIDIN-3-YL)ACETONITRILE HEMINAPHTHYLDISULFONATE AS JANUS KINASE INHIBITOR | 2016 |
|
RU2644155C1 |
| ANTIHISTAMINE PREPARATION "SUBRESTIN" | 2002 |
|
RU2203663C1 |
| MEDICINAL AGENT "FLUSOL" ELICITING ANTIFUNGAL EFFECT | 2001 |
|
RU2201230C1 |
